Related articles

Amino acids are the building blocks of proteins and play a crucial role in muscle maintenance, immune function, and cellular repair. Intravenous (IV) amino acid therapy is often used in cancer patients who suffer from malnutrition, muscle wasting (cachexia), and treatment-related side effects. This article explores the scientific mechanisms, clinical evidence, and benefits of IV amino acid therapy in cancer care.

Albumin is a crucial protein in the blood that plays a vital role in maintaining oncotic pressure, transporting nutrients, and supporting immune function. Intravenous (IV) albumin therapy is often used in cancer patients who experience hypoalbuminemia (low albumin levels) due to malnutrition, chronic inflammation, or cancer-related cachexia. This article explores the scientific mechanisms, clinical evidence, and therapeutic benefits of IV albumin therapy in cancer care.

Glutathione is a powerful antioxidant found in every cell of the body, playing a crucial role in detoxification, immune function, and cellular protection. Intravenous (IV) glutathione therapy has gained attention in integrative oncology due to its potential anti-cancer properties, protection against chemotherapy toxicity, and support for overall well-being. This article explores the scientific mechanisms, clinical evidence, and benefits of IV glutathione therapy for cancer patients.

Alpha-Lipoic Acid (ALA) is a naturally occurring antioxidant and metabolic cofactor that plays a critical role in energy production, oxidative stress reduction, and mitochondrial function. Intravenous (IV) ALA therapy has gained attention in integrative oncology due to its potential anti-cancer effects, neuroprotective properties, and ability to reduce chemotherapy-induced side effects. This article explores the scientific mechanisms, clinical evidence, and therapeutic benefits of IV ALA therapy in cancer care.

Vitamin D plays a crucial role in maintaining overall health, particularly in bone metabolism, immune function, and inflammation regulation. Recent studies suggest that intramuscular injection (IMI) of high-dose Vitamin D may offer additional benefits for cancer patients by supporting immune responses and inhibiting tumor progression. This article explores the scientific rationale, clinical evidence, and potential benefits of IMI Vitamin D in oncology.

Hyperbaric Oxygen Therapy (HBOT) involves breathing 100% oxygen in a pressurized chamber, which increases oxygen levels in the blood and tissues. This therapy has been studied as a potential adjunct treatment for cancer patients, particularly for its ability to enhance oxygenation, reduce hypoxia-induced tumor growth, and improve treatment outcomes. This article explores the scientific mechanisms, clinical evidence, and potential benefits of HBOT in oncology.

Mistletoe (Viscum album) has been used in integrative oncology for decades as an adjunct therapy for cancer patients. Intravenous (IV) mistletoe therapy is believed to have immune-modulating, anti-cancer, and quality-of-life-enhancing properties. It is widely used in Europe, particularly in Germany and Switzerland, as part of complementary cancer care. This article explores the scientific mechanisms, clinical evidence, and potential benefits of IV mistletoe therapy in cancer treatment.

In the realm of integrative oncology, intravenous (IV) high-dose vitamin C (HDIVC) has gained attention as a complementary treatment for cancer patients. Unlike oral vitamin C, which has limited absorption due to gastrointestinal regulation, IV administration allows for significantly higher plasma concentrations, potentially exerting pro-oxidant effects against cancer cells. But what does the science say? This article delves into the scientific rationale, clinical evidence, and potential benefits of HDIVC for cancer patients.